about
Is there a distinction between malaria treatment and intermittent preventive treatment? Insights from a cross-sectional study of anti-malarial drug use among Ugandan pregnant women.Characterizing plasma albumin concentration changes in TB/HIV patients on anti retroviral and anti -tuberculosis therapy.Intermittent use of sulphadoxine-pyrimethamine for malaria prevention: a cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic.Trimester-Specific Population Pharmacokinetics and Other Correlates of Variability in Sulphadoxine-Pyrimethamine Disposition Among Ugandan Pregnant Women.Transition modeling of neuropsychiatric impairment in HIV.CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa population.Markov model for characterizing neuropsychologic impairment and Monte Carlo simulation for optimizing efavirenz therapy.A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients
P50
Q30649452-828AD1D8-B10B-46AB-8C45-1B0881B42EBFQ34235116-00C1618A-9491-4C30-9976-4C035ADF7D3BQ34410295-6183DDD9-A823-490B-B6F9-176AA3DCE430Q36327790-EDFC7066-3A19-4A6E-9A8F-47456AA81C4CQ38854880-55238BF1-5999-47E2-BC12-D10BB4A4D749Q38855121-B87511AC-6511-42AA-8E70-5FCE56F514D7Q38859179-F5DCDAD8-EF85-4FD0-B88B-D68129D182F3Q56909671-01920033-42A6-4ED2-8D8A-450EEA3D5FF1
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kuteesa R Bisaso
@ast
Kuteesa R Bisaso
@en
Kuteesa R Bisaso
@es
Kuteesa R Bisaso
@nl
type
label
Kuteesa R Bisaso
@ast
Kuteesa R Bisaso
@en
Kuteesa R Bisaso
@es
Kuteesa R Bisaso
@nl
prefLabel
Kuteesa R Bisaso
@ast
Kuteesa R Bisaso
@en
Kuteesa R Bisaso
@es
Kuteesa R Bisaso
@nl
P106
P1153
56624549800
P31
P496
0000-0001-7721-4005